Difficulty: Medium
Average Score: 68%
Practice
Which of the following is a leukotriene receptor blocker?
Correct answer
E
Rationale
In this pharmacology CNS drugs quiz, the correct answer is E) LTC4, which is a leukotriene receptor blocker. Leukotrienes are inflammatory mediators involved in conditions like asthma and allergic rhinitis. Leukotriene receptor blockers, such as montelukast and zafirlukast, bind to leukotriene receptors, reducing inflammation and constriction of airways.
Option A) Alprostadil is a prostaglandin used to treat erectile dysfunction and certain heart conditions, not a leukotriene receptor blocker.
Option B) Aspirin is a nonsteroidal anti-inflammatory drug (NSAID) that inhibits prostaglandin synthesis but does not block leukotriene receptors.
Option C) Ibuprofen is another NSAID that works by inhibiting prostaglandin synthesis, not by blocking leukotriene receptors.
Educational Context: Understanding the mechanisms of action of different drug classes is crucial in pharmacology. Knowing which drugs target specific receptors or pathways helps healthcare professionals make informed decisions when selecting appropriate treatments for patients. In the case of CNS drugs, such as leukotriene receptor blockers, grasping their role in managing conditions like asthma can significantly impact patient outcomes.
Option A) Alprostadil is a prostaglandin used to treat erectile dysfunction and certain heart conditions, not a leukotriene receptor blocker.
Option B) Aspirin is a nonsteroidal anti-inflammatory drug (NSAID) that inhibits prostaglandin synthesis but does not block leukotriene receptors.
Option C) Ibuprofen is another NSAID that works by inhibiting prostaglandin synthesis, not by blocking leukotriene receptors.
Educational Context: Understanding the mechanisms of action of different drug classes is crucial in pharmacology. Knowing which drugs target specific receptors or pathways helps healthcare professionals make informed decisions when selecting appropriate treatments for patients. In the case of CNS drugs, such as leukotriene receptor blockers, grasping their role in managing conditions like asthma can significantly impact patient outcomes.